Filing Details
- Accession Number:
- 0000950170-25-074304
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-19 16:04:07
- Reporting Period:
- 2025-05-19
- Filing Date:
- 2025-05-19
- Accepted Time:
- 2025-05-19 16:04:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1395937 | Syndax Pharmaceuticals Inc | SNDX | Pharmaceutical Preparations (2834) | 320162505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1495411 | A. Keith Goldan | 730 Third Avenue Floor 9 New York NY 10017 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-19 | 3,000 | $0.00 | 93,746 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase prices ranged from $8.8465 to $9.2825.
Billionaire Hedge Funds
